Sun Pharmaceutical Industries to Acquire 100% of Innovcare Lifesciences for ₹271 Crore

Deal Summary

Sun Pharmaceutical Industries announced it has signed an agreement to acquire Innovcare Lifesciences in an all‑cash transaction valued at ₹271 crore ($28.73 million). The acquisition gives Sun Pharma full ownership and is expected to close on or before July 31, 2026.